Related references
Note: Only part of the references are listed.Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease
Sandro Fenu et al.
BEHAVIOURAL PHARMACOLOGY (2009)
A reassessment of risks and benefits of dopamine agonists in Parkinson's disease
Angelo Antonini et al.
LANCET NEUROLOGY (2009)
The glutamate homeostasis hypothesis of addiction
Peter W. Kalivas
NATURE REVIEWS NEUROSCIENCE (2009)
The Gambling Symptom Assessment Scale (G-SAS): A reliability and validity study
Suck Won Kim et al.
PSYCHIATRY RESEARCH (2009)
Amantadine-Induced Psychosis in a Young Healthy Patient
Earl Justice Smith
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Non-dopaminergic treatments in development for Parkinson's disease
Susan H. Fox et al.
LANCET NEUROLOGY (2008)
Amantadine may reverse punding in Parkinson's disease - Observation in a patient
Kenichi Kashihara et al.
MOVEMENT DISORDERS (2008)
Association between pathologic gambling and parkinsonian therapy as detected in the food and drug administration adverse event database
A Szarfman et al.
ARCHIVES OF NEUROLOGY (2006)
Reliability and validity of the pathological gambling adaptation of the Yale-Brown obsessive-compulsive scale (PG-YBOCS)
Stefano Pallanti et al.
JOURNAL OF GAMBLING STUDIES (2005)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
